Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s displayed system/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This represents a platform update rather than a change to the underlying study information.SummaryDifference0.1%

- Check18 days agoChange DetectedThe site version was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedParaganglioma was added to the study conditions and a Genetic and Rare Diseases Information Center resource was included. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check54 days agoChange Detected- Revision label updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded Revision: v3.4.2 to the page. Deleted the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check90 days agoChange DetectedA government funding notice banner was added to the page. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.